The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours-Reference-Cited by-同舟云学术

The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours

Published:2007-02 Issue:1 Volume:33 Page:64-77
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Mano Max S.,Rosa Daniela D.,De Azambuja Evandro,Ismael Gustavo F.V.,Durbecq Virginie

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference162 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

2. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease;Cobleigh;J Clin Oncol,1999

3. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer;Vogel;J Clin Oncol,2002

4. A phase III randomized, open-label, international study comparing lapatinib and capecitabine vs capecitabine in women with refractory advanced or metastatic breast cancer (EGF100151);Geyer;ASCO,2006

5. Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly×4 schedule;Ghielmini;Blood,2004

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BayeSMART: Bayesian Clustering of Multi-sample Spatially Resolved Transcriptomics Data;2024-09-01

2. The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer;Breast Cancer;2024-04-01

3. Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer;Nature Communications;2023-08-22

4. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer;Breast Cancer Research and Treatment;2022-03-16

5. Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions;Nature Communications;2021-10-14